Status:
NOT_YET_RECRUITING
PUFAs in Preterm Infants
Lead Sponsor:
The First Hospital of Jilin University
Conditions:
Necrotizing Enterocolitis
Intraventricular Hemorrhage
Eligibility:
All Genders
Brief Summary
The research endeavors to examine the critical composition of Polyunsaturated Fatty Acids (PUFAs) in premature infants across different gestational stages and under varying disease conditions, and del...
Eligibility Criteria
Inclusion
- Infants born between 24 and 36 weeks of gestational age who are admitted within 24 hours of birth, including both premature and full-term newborns.
- \-
Exclusion
- Infants with severe congenital developmental abnormalities, those requiring external supplementation of PUFAs in addition to standard intravenous nutrition and breastfeeding, and those with a severe prognosis indicating non-survival during their hospitalization.
- \-
Key Trial Info
Start Date :
September 21 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2026
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT06045130
Start Date
September 21 2023
End Date
August 31 2026
Last Update
September 21 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.